Antagonist of Secondary Lymphoid-Tissue Chemokine (CCR Ligand 21) Prevents the Development of Chronic Graft-Versus-Host Disease in Mice
Authors:
- 1 January 2003
- journal article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 170 (1) , 588-596
Abstract
The use of receptor antagonists for chemokines is an alternative approach to blocking chemokine actions and has the potential to provide novel therapeutics. We determined the receptor antagonist properties of murine N-terminally truncated secondary lymphoid tissue chemokine (SLC)/6Ckine/CCR ligand 21 analogs and evaluated the preventive effects of SLC antagonists on chronic graft-vs-host disease (GVHD) in a murine model by blocking the homing of donor CCR7-expressing T cells into the recipient’s lymphoid organs. SLC analogs truncated >4 aa residues from the N terminus showed a loss of chemotaxis and Ca2+ influx of CCR7-expressing cells and also inhibited SLC-stimulated chemotaxis and SLC-induced Ca2+ influx completely. To determine whether SLC antagonist inhibits the development of chronic GVHD, chronic GVHD was induced by injecting DBA/2 spleen cells into (C57BL/6 × DBA/2) F1 mice. Total numbers of spleen cells and host B cells, serum levels of IgE, and of total IgG and IgG1 of anti-DNA Abs in SLC antagonist-treated GVHD mice were significantly lower than those in control PBS-treated GVHD mice. This was due to a reduction in the levels of activated donor CD4+ T cells and a decrease in IL-4 production, resulting in a reduction in the numbers of activated host B cells. Therefore, our results suggest that SLC antagonist has beneficial effects for the prevention of chronic GVHD.Keywords
This publication has 58 references indexed in Scilit:
- Structure, Function, and Inhibition of ChemokinesAnnual Review of Pharmacology and Toxicology, 2002
- Localization of Distinct Peyer's Patch Dendritic Cell Subsets and Their Recruitment by Chemokines Macrophage Inflammatory Protein (Mip)-3α, Mip-3β, and Secondary Lymphoid Organ ChemokineJournal of Experimental Medicine, 2000
- A randomised, prospective comparison of allogeneic bone marrow and peripheral blood progenitor cell transplantation in the treatment of haematological malignanciesBone Marrow Transplantation, 1998
- Crystal structure of chemically synthesized [N33A] stromal cell-derived factor 1α, a potent ligand for the HIV-1 “fusin” coreceptorProceedings of the National Academy of Sciences, 1998
- Structural characterization of a monomeric chemokine: Monocyte chemoattractant protein‐3FEBS Letters, 1996
- Lymphocyte Homing and HomeostasisScience, 1996
- Heteronuclear (1H,13C,15N) NMR Assignments and Solution Structure of the Monocyte Chemoattractant Protein-1 (MCP-1) Dimer,Biochemistry, 1996
- Hyper IgE in stimulatory graft-versus-hostdisease: role of interleukin-4Clinical and Experimental Immunology, 1991
- T-cell interactions in autoimmunityImmunology Today, 1988
- Graft-versus-host reactions: clues to the etiopathology of a spectrum of immunological diseasesImmunology Today, 1984